儿科头皮黑色素瘤的特征,治疗方法和结果
Mia A Mologousis1,2,3, Danna Moustafa4, Elena B Hawryluk2,3
1Tufts University School of Medicine, Boston, Massachusetts, USA.
Pediatric dermatology
|December 21, 2023
概括
儿科头皮黑色素瘤是儿童皮肤癌最致命的形式,存在各种亚型. 进一步收集数据对于改善识别和患者护理至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 皮肤病学 皮肤病学
- 癌症研究 癌症研究
背景情况:
- 儿童头皮黑色素瘤与所有解剖位置中死亡率最高相关.
- 早期识别和诊断对于改善儿科癌症患者的治疗结果至关重要.
研究的目的:
- 描述儿科头皮黑色素瘤的不同临床表现.
- 突出了对儿科头皮黑色素瘤增加数据编译的需要.
主要方法:
- 五名被诊断患有头皮黑色素瘤的儿科患者的回顾性病例系列.
- 从马萨诸塞总医院和波士顿儿童医院在2018年至2022年期间收集的数据.
主要成果:
- 观察到的黑色素瘤亚型包括细胞蓝色神经关联,化合物神经关联,状,结节性和表面扩散.
- 该研究确定了儿童头皮黑色素瘤的一系列表现.
结论:
- 儿科头皮黑色素瘤表现出多种表现,这强调了综合诊断方法的重要性.
- 进一步的研究和数据聚合对于提高儿童头皮黑色素瘤的识别和管理至关重要.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Changes in Skin Color: Clinical Perspectives
2.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355


